(19)
(11) EP 1 545 572 A2

(12)

(88) Date of publication A3:
06.05.2005

(43) Date of publication:
29.06.2005 Bulletin 2005/26

(21) Application number: 02739474.1

(22) Date of filing: 23.05.2002
(51) International Patent Classification (IPC)7A61K 38/00, A61K 38/04, A61K 38/28, A61K 31/70, C07K 14/00, C07K 16/00, C07K 17/00
(86) International application number:
PCT/US2002/016819
(87) International publication number:
WO 2002/095007 (28.11.2002 Gazette 2002/48)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 23.05.2001 US 293267 P

(71) Applicant: Dendreon Corporation
Seattle, Washington 98121 (US)

(72) Inventors:
  • MADISON, Edwin, L.
    San Diego, CA 92121 (US)
  • SEMPLE, Joseph, Edward
    San Diego, CA 92131 (US)
  • VLASUK, George, P.
    Carlsbad, CA 92009 (US)
  • KEMP, Scott, Jeffrey
    San Diego, CA 92122 (US)
  • KOMANDLA, Mallareddy
    San Diego, CA 92122 (US)
  • SIEV, Daniel, Vanna
    San Diego, CA 92126 (US)

(74) Representative: Baldock, Sharon Claire et al
BOULT WADE TENNANT,Verulam Gardens70 Gray's Inn Road
London WC1X 8BT
London WC1X 8BT (GB)

   


(54) CONJUGATES ACTIVATED BY CELL SURFACE PROTEASES AND THERAPEUTIC USES THEREOF